Eli Lilly has announced the withdrawal of Xigris [drotrecogin alfa] in all markets based on trial results News item 15 January 2013 Pages: 2 - 2
Health Canada is reviewing the heart-related safety of citalopram Media release 15 January 2013 Pages: 2 - 2
Pravachol [pravastatin] and Mevacor [lovastatin] have the best muscle-related safety profile of statins marketed in the US, Media release 15 January 2013 Pages: 3 - 3
Un-willingness to pay for adverse drug event regulatory actions Clinical study 15 January 2013 Pages: 4 - 4
Progression-free survival more important than ADRs in RCC Clinical study 15 January 2013 Pages: 4 - 4